Adapting to multiple personalities: Cbl is also a RING finger ubiquitin ligase

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1471, Issue 1, 2000, Pages

  Sawasdikosol, Sansana ^a   Pratt, Joanne C ^a   Meng, Wuyi ^a   Eck, Michael J ^a   Burakoff, Steven J ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Adapter protein; Cbl; Protein tyrosine kinase; TCR signal transduction; Ubiquitin ligase

Indexed keywords

PHOSPHOPROTEIN; UBIQUITIN PROTEIN LIGASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN STRUCTURE; SHORT SURVEY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CARRIER PROTEINS; GENE EXPRESSION REGULATION; LIGASES; MODELS, MOLECULAR; ONCOGENE PROTEIN V-CBL; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-CBL; RETROVIRIDAE PROTEINS, ONCOGENIC; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; UBIQUITIN-PROTEIN LIGASES;

EID: 0034738464     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-419X(00)00013-5     Document Type: Short Survey

References (66)

1. Langdon W.Y., Hartley J.W., Klinken S.P., Ruscetti S.K., Morse H.C. v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc. Natl. Acad. Sci. USA. 86:1989;1168-1172.
2. Blake T.J., Shapiro M., Morse H.C.I., Langdon W.Y. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene. 6:1991;653-657.
3. Keane M.M., Riverolezcano O.M., Mitchell J.A., Robbins K.C., Lipkowitz S. Cloning and characterization of cbl-b - a SH3 binding protein with homology to the c-cbl proto-oncogene. Oncogene. 10:1995;2367-2377.
4. Keane M.M., Ettenberg S.A., Nau M.M., Banerjee P., Cuello M., Penninger J. cbl-3: a new mammalian cbl family protein. Oncogene. 18:1999;3365-3375.
5. Yoon C.H., Lee J.H., Jongeward G.D., Sternberg P.W. Similarity of Sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl. Science. 269:1995;1102-1105.
6. Meisner H., Conway B.R., Hartley D., Czech M.P. Interaction of Cbl with Grb2 and phosphatidylinositol 3′-kinase in activated Jurkat cells. Mol. Cell. Biol. 15:1995;3571-3578.
7. Meng W.Y., Sawasdikosol S., Burakoff S.J., Eck M.J. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature. 398:1999;84-90.
8. Smit L., Borst J. The Cbl family of signal transduction molecules. Crit. Rev. Oncogen. 8:1997;359-379.
9. Thien C.B.F., Langdon W.Y. c-Cbl: A regulator of T cell receptor-mediated signalling. Immunol. Cell Biol. 76:1998;473-482.
10. Liu Y.C., Altman A. Cbl - complex formation and functional implications. Cell. Signal. 10:1998;377-385.
11. Lupher M.L., Andoniou C.E., Bonita D., Miyake S., Band H. The c-Cbl oncoprotein. Int. J. Biochem. Cell Biol. 30:1998;439-444.
12. Lupher M.L., Rao N., Eck M.J., Band H. The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction. Immunol. Today. 20:1999;375-382.
13. C.A.P. Joazeiro, S.S. Wing, H. H.K., J.D. Leverson, T. Hunter, Y.C. Liu, The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286 (1999) 309-312.
14. Andoniou C.E., Thien C.B.F., Langdon W.Y. Tumour induction by activated abl involves tyrosine phosphorylation of the product of the Cbl oncogene. EMBO J. 13:1994;4515-4523.
15. Meisner H., Daga A., Buxton J., Fernandez B., Chawla A., Banerjee U. Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development. Mol. Cell. Biol. 17:1997;2217-2225.
16. Jongeward G.D., Clandinin T.R., Sternberg P.W. Sli-1, a negative regulator of let-23-mediated signaling in C. elegans. Genetics. 139:1995;1553-1566.
17. Lupher M.L. Jr., Reedquist K.A., Miyake S., Langdon W.Y., Band H. A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells. J. Biol. Chem. 271:1996;24063-24068.
18. Lupher M.L. Jr., Songyang Z., Shoelson S.E., Cantley L.C., Band H. The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70. J. Biol. Chem. 272:1997;33140-33144.
19. Kong G., Dalton M., Wardenburg J.B., Straus D., Kurosaki T., Chan A.C. Distinct tyrosine phosphorylation sites in ZAP-70 mediate activation and negative regulation of antigen receptor function. Mol. Cell. Biol. 16:1996;5026-5035.
20. Zhao Q., Weiss A. Enhancement of lymphocyte responsiveness by a gain-of-function mutation of ZAP-70. Mol. Cell. Biol. 16:1996;6765-6774.
21. Keshvara L.M., Isaacson C.C., Yankee T.M., Sarac R., Harrison M.L., Geahlen R.L. Syk- and Lyn-dependent phosphorylation of Syk on multiple tyrosines following B cell activation includes a site that negatively regulates signaling. J. Immunol. 161:1998;5276-5283.
22. Zhou M.M., Ravichandran K.S., Olejniczak E.F., Petros A.M., Meadows R.P., Harlan J.E., Wade W.S., Burakoff S.J., Fesik S.W. Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature. 378:1995;584-592.
23. Blake T.J., Heath K.G., Langdon W.Y. The truncation that generated the v-Cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation. EMBO J. 12:1993;2017-2026.
24. Waterman H., Levkowitz G., Alroy I., Yarden Y. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. J. Biol. Chem. 274:1999;22151-22154.
25. Yokouchi M., Kondo T., Houghton A., Bartkiewicz M., Horne W.C., Zhang H., Yoshimura A., Baron R. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J. Biol. Chem. 274:1999;31707-31712.
26. Wang Y., Yeung Y.G., Langdon W.Y., Stanley E.R. C-cbl is transiently tyrosine-phosphorylated, ubiquitinated, and membrane-targeted following CSF-1 stimulation of macrophages. J. Biol. Chem. 271:1996;17-20.
27. Lee P.S.W., Wang Y., Dominguez M.G., Yeung Y.G., Murphy M.A., Bowtell D.D.L. The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation. EMBO J. 18:1999;3616-3628.
28. Levkowitz G., Waterman H., Zamir E., Kam Z., Oved S., Langdon W.Y., Geiger B., Yarden Y. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 12:1998;3663-3674.
29. Miyake S., Lupher M.L., Druker B., Band H. The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha. Proc. Natl. Acad. Sci. USA. 95:1998;7927-7932.
30. Miyake S., Mullane-Robinson K.P., Lill N.L., Douillard P., Band H. Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation - A critical role for Cbl tyrosine kinase-binding domain. J. Biol. Chem. 274:1999;16619-16628.
31. Honda R., Tanaka H., Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:1997;25-27.
32. Hu G., Fearon E.R. Siah-1 N-terminal RING domain is required for proteolysis function, and C-terminal sequences regulate oligomerization and binding to target proteins. Mol. Cell. Biol. 19:1999;724-732.
33. Stebbins C.E., Kaelin W.G.J., Pavletich N.P. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science. 284:1999;455-461.
34. Kamura T., Koepp D.M., Conrad M.N., Skowyra D., Moreland R.J., Iliopoulos O., Lane W.S., Kaelin W.G.J., Elledge S.J., Conaway R.C., Harper J.W., Conaway J.W. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science. 284:1999;657-661.
35. Skowyra D., Koepp D.M., Kamura T., Conrad M.N., Conaway R.C., Conaway J.W., Elledge S.J., Harper J.W. Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1. Science. 284:1999;662-665.
36. Lorick K.L., Jensen J.P., Fang S., Ong A.M., Hatakeyama S., Weissman A.M. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA. 96:1999;11364-11369.
37. Miyake S., Lupher M.L. Jr., Andoniou C.E., Bonita D., Miyake S., Band H. From an enigmatic oncogene to center stage of signal transduction. Crit. Rev. Oncogen. 8:1997;189-218.
38. Hunter S., Burton E.A., Wu S.C., Anderson S.M. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase. J. Biol. Chem. 274:1999;2097-2106.
39. Howlett C.J., Bisson S.A., Resek M.E., Tigley A.W., Robbins S.M. The proto-oncogene p120 (Cbl) is a downstream substrate of the Hck protein-tyrosine kinase. Biochem. Biophys. Res. Commun. 251:1999;129-139.
40. Deckert M., Elly C., Altman A., Liu Y.C. Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases. J. Biol. Chem. 273:1998;8867-8874.
41. Ota Y., Beitz L.O., Scharenberg A.M., Donovan J.A., Kinet J.P., Samelson L.E. Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells. J. Exp. Med. 184:1996;1713-1723.
42. Buday L., Khwaja A., Sipeki S., Farago A., Downward J. Interaction of Cbl with two adapter proteins, Grb2 and Crk, upon T cell activation. J. Biol. Chem. 16:1996;6159-6163.
43. Panchamoorthy G., Fukazawa T., Miyake S., Soltoff S., Reedquist K., Druker B., Shoelson S., Cantley L., Band H. p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase. J. Biol. Chem. 271:1996;3187-3194.
44. van Leeuwen J.E.M., Samelson L.E. T cell antigen-receptor signal transduction. Curr. Opin. Immunol. 11:1999;242-248.
45. Ribon V., Printen J.A., Hoffman N.G., Kay B.K., Saltiel A.R. A novel, multifunctional c-Cbl binding protein in insulin receptor signaling in 3t3-L1 adipocytes. Mol. Cell. Biol. 18:1998;872-879.
46. Ribon V., Herrera R., Kay B.K., Saltiel A.R. A role for CAP, a novel, multifunctional Src homology 3 domain-containing protein in formation of actin stress fibers and focal adhesions. J. Biol. Chem. 273:1998;4073-4080.
47. Blank V., Andrews N.C. The Maf transcription factors: regulators of differentiation. Trends Biochem. Sci. 22:1997;437-441.
48. Luscher B., Larsson L.G. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Oncogene. 18:1999;2955-2966.
49. Bartkiewicz M., Houghton A., Baron R. Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl. A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor. J. Biol. Chem. 274:1999;30887-30895.
50. Zhang Z.H., Elly C., Altman A., Liu Y.C. Dual regulation of T cell receptor-mediated signaling by oncogenic Cbl mutant 70Z. J. Biol. Chem. 274:1999;4883-4889.
51. van Leeuwen J.E., Paik P.K., Samelson L.E. The oncogenic 70Z Cbl mutation blocks the phosphotyrosine binding domain-dependent negative regulation of ZAP-70 by c-Cbl in Jurkat T cells. Mol. Cell. Biol. 19:1999;6652-6664.
52. van Leeuwen J.E.M., Paik P.K., Samelson L.E. Activation of nuclear factor of activated T cells (NFAT) and activating protein 1 (AP-1) by oncogenic 70Z Cbl requires an intact phosphotyrosine binding domain but not Crk(L) or p85 phosphatidylinositol 3-kinase association. J. Biol. Chem. 274:1999;5153-5162.
53. Boussiotis V.A., Freeman G.J., Berezovskaya A., Barber W.L., Nadler L.M. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science. 278:1997;124-128.
54. Liu Y.C., Liu Y., Elly C., Yoshida H., Lipkowitz S., Altman A. Serine phosphorylation of Cbl induced by phorbol ester enhances its association with 14-3-3 proteins in T cells via a novel serine-rich 14-3-3 binding motif. J. Biol. Chem. 272:1997;9979-9985.
55. Yaffe M.B., Rittinger K., Volinia S., Caron P.R., Aitken A., Leffers H., Gamblin S.J., Smerdon S.J., Cantley L.C. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell. 91:1997;961-971.
56. Murphy M.A., Schnall R.G., Venter D.J., Barnett L., Bertoncello I., Thien C.B.F., Langdon W.Y., Bowtell D.D.L. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol. Cell. Biol. 18:1998;4872-4882.
57. Thien C.B.F., Bowtell D.D.L., Langdon W.Y. Perturbed regulation of ZAP-70 and sustained tyrosine phosphorylation of LAT and SLP-76 in c-Cbl-deficient thymocytes. J. Immunol. 162:1999;7133-7139.
58. Tang J., Sawasdikosol S., Chang J.H., Burakoff S.J. SLAP, a dimeric adapter protein, plays a functional role in T cell receptor signaling. Proc. Natl. Acad. Sci. USA. 96:1999;9775-9780.
59. Sosinowski T., Pandey A., Dixit V.M., Weiss A. Src-like adaptor protein (SLAP) is a negative regulator of T cell receptor signaling. J. Exp. Med. 191:2000;463-474.
60. Roche S., Alonso G., Kazlauskas A., Dixit V.M., Courtneidge S.A., Pandey A. Src-like adaptor protein (Slap) is a negative regulator of mitogenis. Curr. Biol. 8:1998;975-978.
61. Zhang Z.H., Elly C., Qiu L., Altman A., Liu Y.C. A direct interaction between the adaptor protein Cbl-b and the kinase Zap-70 induces a positive signal in T cells. Curr. Biol. 9:1999;203-206.
62. Widmann C., Gibson S., Johnson G.L. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J. Biol. Chem. 273:1998;7141-7147.
63. Denis G., Mandard S., Humblet C., Verlaet M., Boniver J., Stehelin D., Regnier D. Nuclear localization of a new c-cbl related protein, CARP 90, during in vivo thymic apoptosis in mice. Cell Death Differ. 6:1999;689-697.
64. Naramura M., Kole H.K., Hu R.J., Gu H. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc. Natl. Acad. Sci. USA. 95:1998;15547-15552.
65. Chiang Y.J., Kole H.K., Brown K., Naramura M., Fukuhara S., Hu R.J., Jang I.K., Gutkind J.S., Shevach E., Gu H. Cbl-b regulates the CD28 dependence of T-cell activation. Nature. 403:2000;216-220.
66. Bachmaier K., Krawczyk C., Kozieradzki I., Kong Y.Y., Sasaki T., Oliveira-dos-Santos A., Mariathasan S., Bouchard D., Wakeham A., Itie A., Le J., Ohashi P.S., Sarosi I., Nishina H., Lipkowitz S., Penninger J.M. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature. 403:2000;211-216.